Adverum Biotechnologies Inc (ADVM) Insider Trading
- $44,603,457.47
- $9,836,653.94
- July 30, 2024
- Mehdi Gasmi
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 30, 2024 | Major Shareholder | 85,800 | $7.15 | Buy | $613,470.00 | |
July 17, 2024 | Major Shareholder | 135,546 | $7.75 | Buy | $1,050,481.50 | |
Feb. 7, 2024 | Director | 100,000 | $1.35 | Buy | $135,000.00 | |
Sept. 15, 2023 | Insider | 6,201 | $1.52 | Sell | $9,425.52 | |
March 15, 2023 | CEO | 41,239 | $0.78 | Sell | $32,166.42 | |
March 15, 2023 | COO | 13,360 | $0.78 | Sell | $10,420.80 | |
March 15, 2023 | Insider | 7,299 | $0.78 | Sell | $5,693.22 | |
Sept. 19, 2022 | CEO | 41,082 | $1.07 | Sell | $43,957.74 | |
Sept. 19, 2022 | Insider | 4,272 | $1.07 | Sell | $4,571.04 | |
May 23, 2022 | Insider | 20,000 | $0.84 | Buy | $16,800.00 | |
May 17, 2022 | CFO | 10,000 | $0.83 | Buy | $8,300.00 | |
May 16, 2022 | Director | 30,000 | $0.85 | Buy | $25,500.00 | |
May 13, 2022 | CFO | 10,000 | $0.86 | Buy | $8,600.00 | |
April 20, 2022 | CEO | 25,000 | $1.11 | Buy | $27,750.00 | |
April 19, 2022 | Insider | 21,925 | $1.14 | Buy | $24,994.50 | |
Dec. 8, 2021 | Insider | 25,000 | $1.91 | Buy | $47,750.00 | |
Dec. 8, 2021 | CEO | 10,677 | $1.79 | Buy | $19,111.83 | |
Nov. 15, 2021 | Director | 50,000 | $2.18 | Sell | $109,000.00 | |
Sept. 30, 2021 | Insider | 4,766 | $2.17 | Sell | $10,342.22 | |
March 24, 2021 | CEO | 10,000 | $9.88 | Buy | $98,800.00 | |
Feb. 9, 2021 | CFO | 12,533 | $14.10 | Sell | $176,715.30 | |
Jan. 15, 2021 | Director | 10,000 | $11.52 | Buy | $115,200.00 | |
Jan. 15, 2021 | CEO | 8,600 | $11.53 | Buy | $99,158.00 | |
Aug. 17, 2020 | insider | 7,692 | $13.00 | Buy | $99,996.00 | |
July 20, 2020 | Director | 5,000 | $17.60 | Sell | $88,000.00 | |
June 22, 2020 | Director | 23,605 | $25.06 | Sell | $591,541.30 | |
June 18, 2020 | Director | 11,395 | $25.01 | Sell | $284,988.95 | |
June 16, 2020 | President | 13,171 | $24.68 | Sell | $325,060.28 | |
June 15, 2020 | Director | 10,000 | $21.86 | Sell | $218,600.00 | |
May 20, 2020 | Director | 1,401 | $20.01 | Sell | $28,034.01 | |
May 18, 2020 | Director | 5,000 | $18.17 | Sell | $90,850.00 | |
May 6, 2020 | CEO | 20,000 | $20.02 | Sell | $400,400.00 | |
May 6, 2020 | Director | 25,000 | $20.03 | Sell | $500,750.00 | |
March 20, 2020 | CEO | 39,526 | $10.17 | Sell | $401,979.42 | |
March 17, 2020 | CEO | 474 | $10.02 | Sell | $4,749.48 | |
Feb. 14, 2020 | Director | 10,000 | $15.79 | Buy | $157,900.00 | |
Feb. 12, 2020 | Director | 10,000 | $15.07 | Sell | $150,700.00 | |
May 6, 2019 | Director | 20,000 | $6.71 | Buy | $134,200.00 | |
June 8, 2015 | Director | 1,192 | $38.64 | Sell | $46,058.88 | |
June 8, 2015 | VP | 500 | $38.64 | Sell | $19,320.00 | |
May 26, 2015 | Director | 1,192 | $36.94 | Sell | $44,032.48 | |
May 22, 2015 | Director | 16,875 | $38.38 | Sell | $647,662.50 | |
May 13, 2015 | CFO | 285 | $34.94 | Sell | $9,957.90 | |
May 13, 2015 | Director | 715 | $34.94 | Sell | $24,982.10 | |
May 8, 2015 | Director | 17,250 | $33.05 | Sell | $570,112.50 | |
April 28, 2015 | VP | 1,000 | $35.67 | Sell | $35,670.00 | |
April 27, 2015 | Director | 1,192 | $35.61 | Sell | $42,447.12 | |
April 23, 2015 | Director | 16,875 | $38.62 | Sell | $651,712.50 | |
April 21, 2015 | VP | 1,000 | $39.21 | Sell | $39,210.00 | |
April 20, 2015 | Director | 1,192 | $40.19 | Sell | $47,906.48 |
Insiders are both buying and selling Adverum Biotechnologies Inc stock.
The insider traders at Adverum Biotechnologies Inc are: Mehdi Gasmi, Laurent Fischer, Paul Wachter, Peter Soparkar, Steven Daniel Schwartz, James Paul Scopa, Leone D Patterson, Braden Michael Leonard, Mark S Blumenkranz, Rupert D'souza, Setareh Seyedkazemi, Zygtech, Llc, James E Flynn, Patrick Machado, Hans Hull, Dawn Svoronos, Regeneron Pharmaceuticals Inc, Richard Beckman, Brigit Riley, Julie Clark, Leone D. Patterson, and Linda Bain
The most active insider trader at Adverum Biotechnologies Inc is Mehdi Gasmi with 12 trades.
Steven Daniel Schwartz has sold the most Adverum Biotechnologies Inc stock with a total value of $3,202,492.50.
James E Flynn has bought the most Adverum Biotechnologies Inc stock with a total value of $63,840,901.28.
The most recent insider trade for Adverum Biotechnologies Inc was on July 30, 2024.
The single biggest insider buy for Adverum Biotechnologies Inc was from James E Flynn with a total value of $31,920,450.64 on Aug. 5, 2014.
The single biggest insider sell for Adverum Biotechnologies Inc was from Hans Hull with a total value of $1,061,500.00 on April 7, 2015.